Drug Shortage Report for INCRUSE ELLIPTA
Report ID | 76337 |
Drug Identification Number | 02423596 |
Brand name | INCRUSE ELLIPTA |
Common or Proper name | umeclidinium (as bromide) dry powder for oral inhalation |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | Umeclidinium |
Strength(s) | 62.5MCG |
Dosage form(s) | POWDER |
Route of administration | INHALATION |
Packaging size | 1x7 |
ATC code | R03BB |
ATC description | |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2019-02-14 |
Estimated end date | 2019-03-05 |
Actual end date | 2019-03-01 |
Shortage status | Resolved |
Updated date | 2019-03-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-02-19 | English | Compare |
v2 | 2019-02-19 | French | Compare |
v3 | 2019-02-27 | English | Compare |
v4 | 2019-02-27 | French | Compare |
v5 | 2019-03-01 | English | Compare |
v6 | 2019-03-01 | French | Compare |
v7 | 2019-03-02 | English | Compare |
Showing 1 to 7 of 7